Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients With Recurrent High Grade Glioma

Trial Profile

Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients With Recurrent High Grade Glioma

Suspended
Phase of Trial: Phase I

Latest Information Update: 20 Jun 2017

At a glance

  • Drugs Terameprocol (Primary)
  • Indications Glioma
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 08 Dec 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2021.
    • 23 Dec 2015 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.
    • 19 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top